Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completedGlobeNewsWire • 02/02/24
The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partnerGlobeNewsWire • 01/29/24
All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. HansenGlobeNewsWire • 01/26/24
Update on the merger approval process for the combination of Novozymes and Chr. Hansen: South Korean merger approval grantedGlobeNewsWire • 12/20/23
Novozymes and Chr. Hansen announce name of future combined company; NovonesisGlobeNewsWire • 12/13/23
Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtainedGlobeNewsWire • 12/12/23
Update on the merger approval process for the combination of Novozymes and Chr. Hansen: The parties have submitted a remedy proposal to the European Commission.GlobeNewsWire • 11/20/23
Novozymes accelerates growth in Q3 and is on track to deliver on full-year expectationsGlobeNewsWire • 10/26/23